Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-04 17:13:28 UTC |
---|
Updated at | 2022-09-04 17:13:29 UTC |
---|
NP-MRD ID | NP0198731 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (3s,3ar,4s,9ar,9bs)-3,6,9-trimethyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate |
---|
Description | (3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3aH,4H,5H,7H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate belongs to the class of organic compounds known as gamma butyrolactones. Gamma butyrolactones are compounds containing a gamma butyrolactone moiety, which consists of an aliphatic five-member ring with four carbon atoms, one oxygen atom, and bears a ketone group on the carbon adjacent to the oxygen atom. (3s,3ar,4s,9ar,9bs)-3,6,9-trimethyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate is found in Achillea millefolium, Artemisia deserti, Artemisia tilesii and Lactuca serriola. It was first documented in 2012 (PMID: 36070501). Based on a literature review a significant number of articles have been published on (3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3aH,4H,5H,7H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate (PMID: 36070500) (PMID: 36070964) (PMID: 36070963) (PMID: 36070962) (PMID: 36070959) (PMID: 36070958). |
---|
Structure | C[C@H]1[C@H]2[C@@H](OC1=O)[C@@H]1C(C)=CC(=O)C1=C(C)C[C@@H]2OC(C)=O InChI=1S/C17H20O5/c1-7-5-11(19)13-8(2)6-12(21-10(4)18)15-9(3)17(20)22-16(15)14(7)13/h5,9,12,14-16H,6H2,1-4H3/t9-,12-,14+,15+,16-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(3S,3AR,4S,9ar,9BS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3ah,4H,5H,7H,9ah,9BH-azuleno[4,5-b]furan-4-yl acetic acid | Generator |
|
---|
Chemical Formula | C17H20O5 |
---|
Average Mass | 304.3420 Da |
---|
Monoisotopic Mass | 304.13107 Da |
---|
IUPAC Name | (3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3aH,4H,5H,7H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate |
---|
Traditional Name | (3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-3H,3aH,4H,5H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate |
---|
CAS Registry Number | Not Available |
---|
SMILES | C[C@H]1[C@H]2[C@@H](OC1=O)[C@@H]1C(C)=CC(=O)C1=C(C)C[C@@H]2OC(C)=O |
---|
InChI Identifier | InChI=1S/C17H20O5/c1-7-5-11(19)13-8(2)6-12(21-10(4)18)15-9(3)17(20)22-16(15)14(7)13/h5,9,12,14-16H,6H2,1-4H3/t9-,12-,14+,15+,16-/m0/s1 |
---|
InChI Key | QONYNSMAVSRIRD-HFDOBSEUSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gamma butyrolactones. Gamma butyrolactones are compounds containing a gamma butyrolactone moiety, which consists of an aliphatic five-member ring with four carbon atoms, one oxygen atom, and bears a ketone group on the carbon adjacent to the oxygen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Lactones |
---|
Sub Class | Gamma butyrolactones |
---|
Direct Parent | Gamma butyrolactones |
---|
Alternative Parents | |
---|
Substituents | - Gamma butyrolactone
- Dicarboxylic acid or derivatives
- Tetrahydrofuran
- Ketone
- Carboxylic acid ester
- Oxacycle
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Authors unspecified: Thalidomide. 2012. [PubMed:36070501 ]
- Authors unspecified: Lenalidomide. 2012. [PubMed:36070500 ]
- Uehara M, Wada-Hiraike O, Koga K, Yamamoto N, Hirano M, Harada M, Hirota Y, Osuga Y: Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study. Endocr J. 2022 Sep 7. doi: 10.1507/endocrj.EJ22-0158. [PubMed:36070964 ]
- Oginosawa Y: Validation of the Implantable Cardioverter-Defibrillators Indication Criteria for Nonischemic Cardiomyopathy- Why? When? How? Circ J. 2022 Sep 6. doi: 10.1253/circj.CJ-22-0478. [PubMed:36070963 ]
- Kodera S, Morita H, Nishi H, Takeda N, Ando J, Komuro I: Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan. Circ J. 2022 Sep 6. doi: 10.1253/circj.CJ-22-0086. [PubMed:36070962 ]
- Niwa R, Ichi S, Nomura R, Sato K: Hypofractionated Stereotactic Radiotherapy with CyberKnife for Large Arteriovenous Malformations and Arteriovenous Malformations Located in Eloquent Areas. Neurol Med Chir (Tokyo). 2022 Oct 15;62(10):445-450. doi: 10.2176/jns-nmc.2022-0033. Epub 2022 Sep 6. [PubMed:36070959 ]
- Cohen RB, Severance G, Olafson SN, Ward CL, Parsikia A, Bloom AR, Moran B, Kaplan MJ, Leung P: Laparoscopic Cholecystectomy in the Time of Coronavirus: A Level-1 Trauma Center's Experience. Am Surg. 2022 Sep 7:31348221121552. doi: 10.1177/00031348221121552. [PubMed:36070958 ]
- Fujino A, Tanaka Y, Abe D, Ariizumi Y, Inaji M, Maehara T: A New Technique for the Endoscopic Reconstruction of Skull Base Defects Using Multiple-balloon Catheters. Neurol Med Chir (Tokyo). 2022 Oct 15;62(10):483-487. doi: 10.2176/jns-nmc.2022-0146. Epub 2022 Sep 6. [PubMed:36070960 ]
- Hara R, Hasegawa E, Inoue N, Sekine A, Tanaka K, Ikuma D, Mizuno H, Oba Y, Yamanouchi M, Suwabe T, Sawa N, Kono K, Kinowaki K, Ohashi K, Ubara Y, Hoshino J: Crescentic Glomerulonephritis with Fibrinoid Vasculitis after Administration of Influenza Vaccine. Intern Med. 2023 Apr 1;62(7):1077-1080. doi: 10.2169/internalmedicine.9410-22. Epub 2022 Sep 6. [PubMed:36070955 ]
- Teranishi K, Mishima Y, Taniguchi T, Fujii T, Nonaka S, Kitamura T, Kondo A, Oishi H: Preliminary Experience of the Surpass Streamline Flow Diverter for Large and Giant Unruptured Internal Carotid Artery Aneurysms. Neurol Med Chir (Tokyo). 2022 Oct 15;62(10):451-457. doi: 10.2176/jns-nmc.2022-0167. Epub 2022 Sep 6. [PubMed:36070961 ]
- Futamura M, Ozaki Y, Makino H, Tsujimoto S, Shigesaka M, Tanaka A, Shimamoto K, Son Y, Ito T, Nomura S: Anti-MDA-5 Antibody-positive Dermatomyositis after Allogeneic Bone Marrow Transplantation for Acute Transformation of Chronic Myelogenous Leukemia. Intern Med. 2023 Apr 1;62(7):1081-1087. doi: 10.2169/internalmedicine.9529-22. Epub 2022 Sep 6. [PubMed:36070956 ]
- Goto R, Kawakami H, Horiuchi Y, Chikada A, Yasuda T, Suzuki T, Miyazato Y, Ishikane M, Kishino Y, Miyazaki H, Igari T, Katano H, Suzuki T, Murayama S, Arai N: An Autopsy Report of a Case with Cerebral Infarction Complicated by Coronavirus Disease 2019 Infection. Intern Med. 2022 Nov 15;61(22):3439-3444. doi: 10.2169/internalmedicine.9726-22. Epub 2022 Sep 6. [PubMed:36070957 ]
- Hamada O, Tsutsumi T, Imanaka Y: Efficiency of the Japanese Hospitalist System for Patients with Urinary Tract Infection: A Propensity-matched Analysis. Intern Med. 2023 Apr 15;62(8):1131-1138. doi: 10.2169/internalmedicine.8944-21. Epub 2022 Sep 6. [PubMed:36070954 ]
- Naito T: Will the Introduction of the Hospitalist System Save Japan? Intern Med. 2023 Apr 15;62(8):1105-1106. doi: 10.2169/internalmedicine.0693-22. Epub 2022 Sep 6. [PubMed:36070953 ]
- Isaac S, Pasha MA, Thinagaran JKR, Kyei-Nimako E: Letter to the editor: Delayed Metastasis of Renal Cell Carcinoma. Intern Med. 2023 May 1;62(9):1385. doi: 10.2169/internalmedicine.0674-22. Epub 2022 Sep 6. [PubMed:36070952 ]
- Yokoyama T, Hayashi D, Kosugi S: Nocardia Subcutaneous Abscess in a Waldenstrom Macroglobulinemia Patient. Intern Med. 2023 Apr 15;62(8):1247-1248. doi: 10.2169/internalmedicine.0496-22. Epub 2022 Sep 6. [PubMed:36070951 ]
- LOTUS database [Link]
|
---|